Fast Pharma News Round-up

WHO hails ‘triumph’ as Merck’s Ebola vaccine gets EU green light

The world’s first Ebola vaccine, developed by Merck & Co, has been approved by the European drugs regulator. The decision could save many lives and is already being used under emergency guidelines in the Democratic Republic of Congo.

(Source: reuters.com)

56% rise in GPs seeking mental health help in last year

GPOline has reported that in September 2019, 1855 GPs had an active case with the initiative that offers free confidential support for doctors and dentists in England. This is compared to 1,188 GPs at the end of the first quarter of the 2018/19 financial year

(Source: Pharmatimes.com)

Bristol-Myers Squibb-Pfizer Alliance and Fitbit collaborate on atrial fibrillation diagnosis

BMS and Pfizer have announced at the TIME 100 Health Summit in New York that they are working with Fitbit to deliver timely atrial fibrillation diagnosis. This is to aim to improve the detection of individuals who have an increased risk of a stroke.

(Source: Pharmafield.co.uk)

DIY drugs: should hospitals make their own medicine?

Is there an alternative to pharmaceutical companies making drugs? Well, one Dutch chemist thinks so.

(Source: theguardian.com)

Lawsuit-ridden J&J tumbles in annual listing of best global brands

The pharma giant has lost half a billion dollars in brand value over the past year, according to Interbrand’s Best Global Brands for 2019 ranking. This is the first time since 2011 that J&J has shed value in the survey, and it appears to be due to a number of ongoing lawsuits against the company.

(Source: Fiercepharma.com)